v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
Total
Common stock
Additional paid-in capital
Accumulated deficit
Non- controlling interests
Beginning balance (in shares) at Dec. 31, 2024   381,476,581      
Beginning balance at Dec. 31, 2024 $ 58,547,000 $ 381,000 $ 173,366,000 $ (113,448,000) $ (1,752,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Release of shares under stock grants (in shares)   1,525,265      
Release of shares under stock grants 0 $ 2,000 (2,000)    
Shares of newly vested common stock surrendered to the Company to satisfy tax withholding obligations (in shares)   (108,161)      
Shares of newly vested stock surrendered to the Company to satisfy tax withholding obligations (9,000)   (9,000)    
Conversion of preferred stock to common stock (in shares)   5,776,370      
Conversion of preferred stock to common stock 4,275,000 $ 6,000 4,269,000    
Common stock issued under licensing agreement (in shares)   9,015      
Common stock issued under licensing agreement 1,000   1,000    
Distributions to non-controlling interests (58,000)       (58,000)
Stock-based compensation 547,000   547,000    
Net (loss) income (5,479,000)     (5,511,000) 32,000
Ending balance (in shares) at Mar. 31, 2025   388,679,070      
Ending balance at Mar. 31, 2025 57,824,000 $ 389,000 178,172,000 (118,959,000) (1,778,000)
Beginning balance (in shares) at Dec. 31, 2024   381,476,581      
Beginning balance at Dec. 31, 2024 58,547,000 $ 381,000 173,366,000 (113,448,000) (1,752,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (6,874,000)        
Ending balance (in shares) at Jun. 30, 2025   392,007,065      
Ending balance at Jun. 30, 2025 56,935,000 $ 392,000 178,698,000 (120,353,000) (1,802,000)
Beginning balance (in shares) at Mar. 31, 2025   388,679,070      
Beginning balance at Mar. 31, 2025 57,824,000 $ 389,000 178,172,000 (118,959,000) (1,778,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Release of shares under stock grants (in shares)   3,568,940      
Release of shares under stock grants 0 $ 3,000 (3,000)    
Shares of newly vested common stock surrendered to the Company to satisfy tax withholding obligations (in shares)   (251,631)      
Shares of newly vested stock surrendered to the Company to satisfy tax withholding obligations (21,000)   (21,000)    
Common stock issued under licensing agreement (in shares)   10,686      
Common stock issued under licensing agreement 1,000   1,000    
Distributions to non-controlling interests (23,000)       (23,000)
Stock-based compensation 549,000   549,000    
Net (loss) income (1,395,000)     (1,394,000) (1,000)
Ending balance (in shares) at Jun. 30, 2025   392,007,065      
Ending balance at Jun. 30, 2025 56,935,000 $ 392,000 178,698,000 (120,353,000) (1,802,000)
Beginning balance (in shares) at Dec. 31, 2025   396,911,368      
Beginning balance at Dec. 31, 2025 50,009,000 $ 397,000 179,405,000 (127,932,000) (1,861,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Release of shares under stock grants (in shares)   2,057,122      
Release of shares under stock grants 0 $ 2,000 (2,000)    
Shares of newly vested common stock surrendered to the Company to satisfy tax withholding obligations (in shares)   (61,868)      
Shares of newly vested stock surrendered to the Company to satisfy tax withholding obligations (5,000)   (5,000)    
Distributions to non-controlling interests (49,000)       (49,000)
Stock-based compensation 325,000   325,000    
Net (loss) income (3,767,000)     (3,785,000) 18,000
Ending balance (in shares) at Mar. 31, 2026   398,906,622      
Ending balance at Mar. 31, 2026 46,513,000 $ 399,000 179,723,000 (131,717,000) (1,892,000)
Beginning balance (in shares) at Dec. 31, 2025   396,911,368      
Beginning balance at Dec. 31, 2025 $ 50,009,000 $ 397,000 179,405,000 (127,932,000) (1,861,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Shares of newly vested common stock surrendered to the Company to satisfy tax withholding obligations (in shares) (243,958)        
Shares of newly vested stock surrendered to the Company to satisfy tax withholding obligations $ (22,000)        
Net (loss) income (7,338,000)        
Ending balance (in shares) at Jun. 30, 2026   401,167,467      
Ending balance at Jun. 30, 2026 43,244,000 $ 401,000 180,054,000 (135,306,000) (1,905,000)
Beginning balance (in shares) at Mar. 31, 2026   398,906,622      
Beginning balance at Mar. 31, 2026 46,513,000 $ 399,000 179,723,000 (131,717,000) (1,892,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Release of shares under stock grants (in shares)   2,442,935      
Release of shares under stock grants 0 $ 2,000 (2,000)    
Shares of newly vested common stock surrendered to the Company to satisfy tax withholding obligations (in shares)   (182,090)      
Shares of newly vested stock surrendered to the Company to satisfy tax withholding obligations (17,000)   (17,000)    
Distributions to non-controlling interests (31,000)       (31,000)
Stock-based compensation 350,000   350,000    
Net (loss) income (3,571,000)     (3,589,000) 18,000
Ending balance (in shares) at Jun. 30, 2026   401,167,467      
Ending balance at Jun. 30, 2026 $ 43,244,000 $ 401,000 $ 180,054,000 $ (135,306,000) $ (1,905,000)